Literature DB >> 4741371

Partial body neutron activation analysis in vivo: a new approach to the investigation of metabolic bone disease.

G R Catto, J A McIntosh, M Macleod.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4741371     DOI： 10.1088/0031-9155/18/4/003

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN： 0031-9155            Impact factor:   3.609


× No keyword cloud information.
  6 in total

1.  The treatment of renal osteodystrophy with 1-alpha-hydroxycholecalciferol.

Authors:  B J Junor; G R Catto; M Macleod
Journal:  Calcif Tissue Res       Date:  1977-05

Review 2.  Measurement of bone mass by total body calcium: a review.

Authors:  D M Reid
Journal:  J R Soc Med       Date:  1986-01       Impact factor: 5.344

3.  Validated measurement of periarticular bone mineral density at the knee joint by dual energy x ray absorptiometry.

Authors:  E Murphy; B Bresnihan; O FitzGerald
Journal:  Ann Rheum Dis       Date:  2001-01       Impact factor: 19.103

4.  I alpha-hydroxycholecalciferol: a treatment of renal bone disease.

Authors:  G R Catto; M MacLeod; B Pelc; E Kodicek
Journal:  Br Med J       Date:  1975-01-04

5.  Measurement of periarticular bone mineral density in the hands of patients with early inflammatory arthritis using dual energy x-ray absorptiometry.

Authors:  Eithne Murphy; Barry Bresnihan; Oliver FitzGerald
Journal:  Clin Rheumatol       Date:  2008-02-21       Impact factor: 2.980

6.  Facility optimization to improve activation rate distributions during IVNAA.

Authors:  Atiyeh Ebrahimi Khankook; Laleh Rafat Motavalli; Hashem Miri Hakimabad
Journal:  J Radiat Res       Date:  2013-02-05       Impact factor: 2.724
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.